There’s an extraordinarily damning overview of the current process for finding out about clinical trials written by Dr Bess Stillman that you can read on Substack at bessstillman.substack.com.

I won’t go into the details but everyone in the industry should read the three part series entitled ‘Please be dying, but not too quickly.’

One of the issues highlighted is a familiar one – the lack of user-friendliness of the main website repository for information about clinical trials: ClinicalTrials.gov.

It is an admittedly small percentage of potential trial participants who actually seek out a trial they could take part in. But for anyone that does, the main platform that is supposed to provide relevant details is hopelessly confusing and almost impossibly difficult to use effectively.

The direction of travel is certainly toward improvement – with layperson’s summaries almost certainly set to be mandated. Let’s hope that website usability comes next, and soon.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...